Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Callisia N. Clarke MD

Callisia N. Clarke MD profile photo picture

Chief, Associate Professor

Institution: Medical College of Wisconsin
Department: Surgery
Division: Surgical Oncology

Member of the Cancer Center


Publications (144)

  • ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms (Hallet J, Clarke CN) Annals of Surgical Oncology March 2024;31(3):1704-1713 SCOPUS ID: 2-s2.0-85181198604 03/01/2024       1 Citation
  • Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy. (Ward EP, Vincent-Sheldon S, Tolat P, Kulkarni N, Aldakkak M, Budithi R, Clarke CN, Tsai S, Evans DB, Christians KK) Surgery 2024 May;175(5):1386-1393 PMID: 38413302 SCOPUS ID: 2-s2.0-85186348752 02/28/2024    
  • Evolution of Surgical Management and Outcomes of Neuroendocrine Tumor Liver Metastases. (Bello RJ, Clarke CN) Ann Surg Oncol 2024 Apr;31(4):2192-2193 PMID: 38273173 SCOPUS ID: 2-s2.0-85183621978 01/26/2024    
  • ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms. (Hallet J, Clarke CN) Ann Surg Oncol 2024 Mar;31(3):1704-1713 PMID: 38167813 SCOPUS ID: 2-s2.0-85181198604 01/04/2024       1 Citation
  • Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy. (de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA) Cancer Med 2023 Dec 22;13(1) PMID: 38140796 PMCID: PMC10807686 SCOPUS ID: 2-s2.0-85180644976 12/23/2023    
  • Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors. (Clarke CN, Cockrum P, Beveridge TJR, Jerry M, McMorrow D, Tran AT, Phan AT) J Health Econ Outcomes Res 2023;10(2):121-131 PMID: 38093906 PMCID: PMC10718524 12/14/2023    
  • Can I Leave? Perspectives on Parental Leave and Parenthood in Medical Training Among Program Directors and Trainees in Oncologic Specialties. (Beltrán Ponce S, Jagsi R, Florez N, Thomas CR Jr, Banerjee A, Jasti S, Bailey MM, Lawton CAF, Johnstone C, Clarke CN, Bedi M, Jovanovic M, Saeed H) J Womens Health (Larchmt) 2024 Feb;33(2):218-227 PMID: 38011014 SCOPUS ID: 2-s2.0-85179389889 11/27/2023    
  • Live to fight another day: Combining parenchymal sparing resection and ablative therapy in neuroendocrine tumor liver metastases. (Bello RJ, Clarke CN) Am J Surg 2024 Mar;229:15-16 PMID: 37985321 SCOPUS ID: 2-s2.0-85178186495 11/21/2023       1 Citation
  • Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal Chemotherapy. (Florissi I, Radomski SN, Shou B, Cloyd JM, Kim A, Grotz T, Fournier K, Baumgartner JM, Lambert L, Abbott DE, Schwartz P, Staley CA, Clarke C, Dineen S, Patel SH, Wilson GC, Raoof M, Johnston FM, Greer JB) J Surg Res 2024 Jan;293:403-412 PMID: 37806228 SCOPUS ID: 2-s2.0-85173471313 10/09/2023    
  • Integration of the social determinants of health into quality indicators for colorectal cancer surgery: a scoping review protocol. (Bondzi-Simpson A, Ribeiro T, Benipal H, Barabash V, Lofters A, Sutradhar R, Snyder RA, Clarke C, Coburn NG, Hallet J) BMJ Open 2023 Sep 26;13(9):e075270 PMID: 37751959 PMCID: PMC10533733 SCOPUS ID: 2-s2.0-85174022015 09/29/2023    
  • ASO Visual Abstract: Neighborhood Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. (Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB) Ann Surg Oncol 2023 Dec;30(13):8178-8179 PMID: 37768415 SCOPUS ID: 2-s2.0-85176495252 09/28/2023    
  • Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. (Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB) Ann Surg Oncol 2023 Nov;30(12):7840-7847 PMID: 37620532 PMCID: PMC10592201 SCOPUS ID: 2-s2.0-85168622027 08/25/2023       1 Citation
  • Severity of Prior Coronavirus Disease 2019 is Associated With Postoperative Outcomes After Major Inpatient Surgery. (Verhagen NB, SenthilKumar G, Jaraczewski T, Koerber NK, Merrill JR, Flitcroft MA, Szabo A, Banerjee A, Yang X, Taylor BW, Figueroa Castro CE, Yen TWF, Clarke CN, Lauer K, Pfeifer KJ, Gould JC, Kothari AN, N3C Consortium) Ann Surg 2023 Nov 01;278(5):e949-e956 PMID: 37476995 PMCID: PMC10659141 SCOPUS ID: 2-s2.0-85173563272 07/21/2023       4 Citations
  • Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer. (SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN) Sci Rep 2023 Jul 08;13(1):11051 PMID: 37422500 PMCID: PMC10329647 SCOPUS ID: 2-s2.0-85164146540 07/09/2023       2 Citations
  • ASO Visual Abstract: Assessing the Complex General Surgical Oncology Pipeline-Trends in Race and Ethnicity Among US Medical Students, General Surgery Residents, and Complex General Surgical Oncology Trainees. (Collins RA, Sheriff SA, Yoon C, Cobb AN, Kothari AN, Newman LA, Dossett LA, Willis AI, Wong SL, Clarke CN) Ann Surg Oncol 2023 Aug;30(8):4587-4588 PMID: 37191861 SCOPUS ID: 2-s2.0-85164243995 05/16/2023    
  • Severity of Prior COVID-19 Infection is Associated with Postoperative Outcomes Following Major Inpatient Surgery. (Verhagen NB, SenthilKumar G, Jaraczewski T, Koerber NK, Merrill JR, Flitcroft MA, Szabo A, Banerjee A, Yang X, Taylor BW, Castro CEF, Yen TWF, Clarke CN, Lauer K, Pfeifer KJ, Gould JC, Kothari AN) medRxiv 2023 Apr 17 PMID: 37131614 PMCID: PMC10153306 05/03/2023    
  • Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer. (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S) Ann Surg 2023 Dec 01;278(6):e1224-e1231 PMID: 37078282 SCOPUS ID: 2-s2.0-85176508848 04/20/2023       1 Citation
  • Assessing the Complex General Surgical Oncology Pipeline: Trends in Race and Ethnicity Among US Medical Students, General Surgery Residents, and Complex General Surgical Oncology Trainees. (Collins RA, Sheriff SA, Yoon C, Cobb AN, Kothari AN, Newman LA, Dossett LA, Willis AI, Wong SL, Clarke CN) Ann Surg Oncol 2023 Aug;30(8):4579-4586 PMID: 37079205 SCOPUS ID: 2-s2.0-85153059305 04/20/2023       3 Citations
  • Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice. (Merrill JR, Flitcroft MA, Miller T, Beichner B, Clarke CN, Maduekwe UN, Wang TS, Dream S, Christians KK, Gamblin TC, Evans DB, Kothari AN) J Surg Res 2023 Aug;288:269-274 PMID: 37037166 SCOPUS ID: 2-s2.0-85151667989 04/11/2023       1 Citation
  • Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S) J Surg Oncol 2023 Jul;128(1):41-50 PMID: 36960919 SCOPUS ID: 2-s2.0-85152449940 03/25/2023       2 Citations
  • ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer. (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S) Ann Surg Oncol 2023 May;30(5):3022 PMID: 36877324 SCOPUS ID: 2-s2.0-85152164746 03/07/2023    
  • CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer. (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S) Ann Surg Oncol 2023 May;30(5):3013-3021 PMID: 36788189 SCOPUS ID: 2-s2.0-85147934173 02/15/2023       1 Citation
  • Clinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma. (Jones S, Henry V, Strong E, Sheriff SA, Wanat K, Kasprzak J, Clark M, Shukla M, Zenga J, Stadler M, Dzwierzynski W, Harker-Murray A, Young K, Kothari AN, Clarke CN) J Surg Res 2023 Jun;286:35-40 PMID: 36739830 SCOPUS ID: 2-s2.0-85147832080 02/06/2023       2 Citations
  • Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors (Clarke CN, Cockrum P, Beveridge TJR, Jerry M, McMorrow D, Tran AT, Phan AT) Journal of Health Economics and Outcomes Research 2023;10(2):121-131 SCOPUS ID: 2-s2.0-85181942733 01/01/2023       1 Citation
  • Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative. (Thalji SZ, Ethun CG, Tsai S, Gamblin TC, Clarke CN, Bedi M, King D, LoGiudice J, Poultsides G, Grignol VP, Tseng J, Votanopoulos K, Fields RC, Cardona K, Mogal H) J Surg Oncol 2023 Mar;127(4):550-559 PMID: 36477427 SCOPUS ID: 2-s2.0-85147711222 12/09/2022       2 Citations
  • Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC. (Kubi B, Nudotor R, Fackche N, Rowe J, Cloyd JM, Ahmed A, Grotz TE, Fournier K, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB) J Surg Oncol 2023 Mar;127(4):706-715 PMID: 36468401 SCOPUS ID: 2-s2.0-85143899672 12/06/2022    
  • Comparison of COVID-19 Rates Among In-Person and Virtual Attendees of a National Surgical Society Meeting in the US. (Silver CM, Joung RH, Morris MS, Wang KS, Ghaferi AA, Bilimoria KY, Clarke CN) JAMA Netw Open 2022 Sep 01;5(9):e2230300 PMID: 36069986 PMCID: PMC9453540 SCOPUS ID: 2-s2.0-85137745353 09/08/2022       3 Citations
  • Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery. (Deng H, Eftekhari Z, Carlin C, Veerapong J, Fournier KF, Johnston FM, Dineen SP, Powers BD, Hendrix R, Lambert LA, Abbott DE, Vande Walle K, Grotz TE, Patel SH, Clarke CN, Staley CA, Abdel-Misih S, Cloyd JM, Lee B, Fong Y, Raoof M) JAMA Netw Open 2022 May 02;5(5):e2212930 PMID: 35612856 PMCID: PMC9133947 SCOPUS ID: 2-s2.0-85131107269 05/26/2022       13 Citations
  • Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective? (Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke CN) J Surg Res 2022 Oct;278:31-38 PMID: 35588572 SCOPUS ID: 2-s2.0-85130316020 05/20/2022       1 Citation
  • Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease? (Beal EW, Chen JC, Kim A, Johnston FM, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Clarke C, Staley C, Patel SH, Lambert L, Cloyd JM) J Surg Res 2022 Sep;277:269-278 PMID: 35525209 SCOPUS ID: 2-s2.0-85129473994 05/08/2022    
  • More than a moment: Why surgical societies must continuously strive for diversification and creating a culture of equity and inclusivity in academic surgery. (Clarke CN) Am J Surg 2022 Jul;224(1 Pt B):292-293 PMID: 35337646 PMCID: PMC9745945 SCOPUS ID: 2-s2.0-85127538368 03/27/2022       3 Citations
  • Surgical Societies Must Lead the Way on Addressing Bias and Microaggressions (Clarke CN) Annals of Surgical Oncology February 2022;29(2):755-757 SCOPUS ID: 2-s2.0-85118456515 02/01/2022    
  • Disparities in Creating a Diverse Surgical Oncology Physician Workforce: Just a Leaky Pipeline? (Clarke CN) Surgical Oncology Clinics of North America January 2022;31(1):21-27 SCOPUS ID: 2-s2.0-85117391754 01/01/2022       10 Citations
  • Epidemiology and risk factors for metastatic colorectal disease (Ward EP, Clarke CN) Contemporary Management of Metastatic Colorectal Cancer: A Precision Medicine Approach 1 January 2022:1-17 SCOPUS ID: 2-s2.0-85152309264 01/01/2022    
  • Commentary on Brief Clinical Report: "Coronary Artery Stent for Securing High-risk Pancreatico-Jejunal Anastomosis After Pancreaticoduodenectomy: A Pilot Series". (Clarke CN, Maduekwe UN) Ann Surg 2022 Apr 01;275(4):e669 PMID: 34913892 SCOPUS ID: 2-s2.0-85126072420 12/17/2021    
  • Disparities in Creating a Diverse Surgical Oncology Physician Workforce: Just a Leaky Pipeline? (Clarke CN) Surg Oncol Clin N Am 2022 Jan;31(1):21-27 PMID: 34776061 SCOPUS ID: 2-s2.0-85117391754 11/16/2021       10 Citations
  • Surgical Societies Must Lead the Way on Addressing Bias and Microaggressions. (Clarke CN) Ann Surg Oncol 2022 Feb;29(2):755-757 PMID: 34727315 SCOPUS ID: 2-s2.0-85118456515 11/03/2021    
  • A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative. (Lee RM, Ethun CG, Gamboa AC, Turgeon MK, Tran T, Poultsides G, Grignol V, Bedi M, Mogal H, Clarke CN, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Oskouei SV, Monson DK, Reimer NB, Maithel SK, Pickens A, Cardona K) J Surg Oncol 2021 Dec;124(8):1477-1484 PMID: 34374088 PMCID: PMC8595861 SCOPUS ID: 2-s2.0-85112074442 08/11/2021       7 Citations
  • Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care. (Clarke CN, Cortina CS, Fayanju OM, Dossett LA, Johnston FM, Wong SL) Ann Surg Oncol 2022 Apr;29(4):2176-2180 PMID: 34097159 SCOPUS ID: 2-s2.0-85107782600 06/08/2021       29 Citations
  • Exploration of machine learning techniques to examine the journey to neuroendocrine tumor diagnosis with real-world data. (Zimmerman NM, Ray D, Princic N, Moynihan M, Clarke C, Phan A) Future Oncol 2021 Aug;17(24):3217-3230 PMID: 34008426 SCOPUS ID: 2-s2.0-85111589518 05/20/2021       2 Citations
  • Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis (Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D’Angelica MI, Aloia TA, Eastwood D, Gamblin TC) Annals of Surgical Oncology March 2021;28(3):1457-1465 SCOPUS ID: 2-s2.0-85098739759 03/01/2021       17 Citations
  • The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. (Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB) J Gastrointest Surg 2021 Nov;25(11):2908-2919 PMID: 33634422 SCOPUS ID: 2-s2.0-85101751461 02/27/2021       4 Citations
  • Xanthomatous Dermal Changes in a Patient With Locally Advanced Basal Cell Carcinoma Treated Using Vismodegib. (Smith SDB, Clarke CN, Clark MA, Harker-Murray AK, Sokumbi O) Am J Dermatopathol 2021 Aug 01;43(8):585-587 PMID: 33534208 SCOPUS ID: 2-s2.0-85112126051 02/04/2021    
  • Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis. (Kubi B, Nudotor R, Fackche N, Nizam W, Cloyd JM, Grotz TE, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Patel SH, Lambert LA, Abbott DE, Vande Walle KA, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Greer JB) Ann Surg Oncol 2021 Aug;28(8):4499-4507 PMID: 33507449 SCOPUS ID: 2-s2.0-85099261399 01/29/2021       9 Citations
  • Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study (Powers BD, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Maithel SK, Patel S, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Johnston FM, Greer J, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Imanirad I, Dessureault S, Dineen SP) Annals of Surgical Oncology December 2020;27(13):4883-4891 SCOPUS ID: 2-s2.0-85083717596 12/01/2020       11 Citations
  • Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S) HPB December 2020;22(12):1745-1752 SCOPUS ID: 2-s2.0-85083782398 12/01/2020       2 Citations
  • Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database. (Stahl CC, Schwartz PB, Ethun CG, Marka N, Krasnick BA, Tran TB, Poultsides GA, Roggin KK, Fields RC, Clarke CN, Votanopoulos KI, Cardona K, Abbott DE) Ann Surg Oncol 2021 Mar;28(3):1690-1696 PMID: 33146839 PMCID: PMC7897241 SCOPUS ID: 2-s2.0-85094955789 11/05/2020       9 Citations
  • Predictors of Nonhome Discharge after Cytoreductive Surgery and HIPEC (Kubi B, Gunn J, Fackche N, Cloyd JM, Abdel-Misih S, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Patel SH, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Wang NY, Greer JB) Journal of Surgical Research November 2020;255:475-485 SCOPUS ID: 2-s2.0-85087132508 11/01/2020       4 Citations
  • The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. (Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Eng O, Johnston FM, Greer J, Grotz TE) Int J Hyperthermia 2020;37(1):1182-1188 PMID: 33040617 SCOPUS ID: 2-s2.0-85092476058 10/13/2020       5 Citations
  • Total Neoadjuvant Therapy for Operable Pancreatic Cancer. (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S) Ann Surg Oncol 2021 Apr;28(4):2246-2256 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020       29 Citations
  • High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. (Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN) Surgery 2020 Oct;168(4):760-767 PMID: 32736869 SCOPUS ID: 2-s2.0-85088789886 08/02/2020       3 Citations
  • Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. (Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA) Ann Surg Oncol 2020 Dec;27(13):4980-4995 PMID: 32696303 PMCID: PMC7988818 SCOPUS ID: 2-s2.0-85088288936 07/23/2020       14 Citations
  • Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi-institutional analysis of the US Sarcoma Collaborative. (Wiseman JT, Ethun CG, Cloyd JM, Shelby R, Suarez-Kelly L, Tran T, Poultsides G, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick B, Fields R, Walle KV, Ronnekleiv-Kelly S, Howard JH, Cardona K, Grignol V) J Surg Oncol 2020 Nov;122(6):1189-1198 PMID: 32696475 SCOPUS ID: 2-s2.0-85088290260 07/23/2020       18 Citations
  • Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication. (Taskin OC, Clarke CN, Erkan M, Tsai S, Evans DB, Adsay V) J Gastrointest Oncol 2020 Jun;11(3):548-558 PMID: 32655934 PMCID: PMC7340800 SCOPUS ID: 2-s2.0-85090285071 07/14/2020       14 Citations
  • Treatment sequencing for pancreatic neuroendocrine tumors: daring to challenge the status quo. (Clarke CN, Evans DB) J Gastrointest Oncol 2020 Jun;11(3):545-547 PMID: 32655933 PMCID: PMC7340804 SCOPUS ID: 2-s2.0-85090280297 07/14/2020       1 Citation
  • Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery 2020 Sep;168(3):440-447 PMID: 32641278 SCOPUS ID: 2-s2.0-85087345792 07/10/2020       13 Citations
  • Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. (Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston FM, Dineen S, Powers B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Walle KV, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M) J Surg Oncol 2020 Oct;122(5):980-985 PMID: 32627199 SCOPUS ID: 2-s2.0-85087448757 07/07/2020       10 Citations
  • Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS-NSQIP risk calculator. (Schwartz PB, Stahl CC, Ethun C, Marka N, Poultsides GA, Roggin KK, Fields RC, Howard JH, Clarke CN, Votanopoulos KI, Cardona K, Abbott DE) J Surg Oncol 2020 Sep;122(4):795-802 PMID: 32557654 PMCID: PMC7744355 SCOPUS ID: 2-s2.0-85086709814 06/20/2020       4 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors (Izquierdo FJ, Plana A, Schuitevoerder D, Hayes-Jordan A, Deneve JL, Al-kasspooles M, Bowne WB, Brown CK, Kane JM, Kelly KJ, Kennedy TJ, Maduekwe UN, Mak GZ, Melis M, Royal R, Abbott DE, Abdel-Misih S, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Catenacci DV, Chan CHF, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Govindarajan A, Grotz TE, Gushchin V, Hanna N, Harmath C, Husain AN, Idrees K, Ihemelandu C, Jiang D, Johnston FM, Lowy AM, Karakousis G, Keutgen XM, Kindler HL, Kluger MD, Lee B, Mack LA, Mammen JMV, Mathew MS, Melnitchouk N, Merkow RP, Mogal H, Möller MG, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Salti G, Sardi A, Senthil M, Setia N, Sideris L, Sherman SK, Skitzki J, Tun S, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C, Sugarbaker PH, Bartlett DL, Turaga K) Annals of Surgical Oncology 1 June 2020;27(6):1793-1797 SCOPUS ID: 2-s2.0-85083346862 06/01/2020       14 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations (Plana A, Izquierdo FJ, Schuitevoerder D, Lambert LA, Micic D, Deneve JL, Ahrendt SA, Al-kasspooles M, Amersi F, Bowne WB, Brown CK, Hayes-Jordan A, Kane JM, Kelly KJ, Kennedy TJ, Maduekwe UN, Mak GZ, Melis M, Royal R, Abbott DE, Abdel-Misih S, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Catenacci DV, Chan CHF, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Govindarajan A, Grotz TE, Gushchin V, Hanna N, Harmath C, Husain AN, Idrees K, Ihemelandu C, In H, Johnston FM, Jiang D, Karakousis G, Keutgen XM, Kindler HL, Kluger MD, Lee B, Lee NK, Liao CY, Mack LA, Malec M, Mammen JMV, Mathew MS, Melnitchouk N, Merkow RP, Mogal H, Möller MG, Nash GM, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Salti G, Sardi A, Semrad C, Senthil M, Setia N, Sherman SK, Sideris L, Sherman SK, Skitzki J, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Lowy AM, Alexander HR, Esquivel J, Foster JM, Labow DM, Levine EA, Staley C) Annals of Surgical Oncology 1 June 2020;27(6):1798-1804 SCOPUS ID: 2-s2.0-85083343126 06/01/2020       13 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms (Hoppenot C, Schuitevoerder D, Izquierdo FJ, Plana A, Pothuri B, Yamada SD, Kim J, Lee NK, Abbott DE, Abdel-Misih S, Ahrendt SA, Al-kasspooles M, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Bowne WB, Brown CK, Catenacci DV, Chan CHF, Chapel DB, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Deneve JL, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Grotz TE, Gushchin V, Hanna N, Harmath C, Hayes-Jordan A, Husain AN, Idrees K, Ihemelandu C, Johnston FM, Jiang D, Kane JM, Karakousis G, Kelly KJ, Kennedy TJ, Keutgen XM, Kindler HL, Kluger MD, Lastra RR, Lee B, Mack LA, Maduekwe UN, Mak GZ, Mammen JMV, Mathew MS, Melis M, Melnitchouk N, Merkow RP, Mogal H, Möller MG, Moroney J, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Royal R, Salti G, Sardi A, Senthil M, Setia N, Sherman SK, Sideris L, Skitzki J, Tun S, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Lowy AM, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C) Annals of Surgical Oncology 1 June 2020;27(6):1780-1787 SCOPUS ID: 2-s2.0-85083287875 06/01/2020       14 Citations
  • Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. (Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC) J Surg Oncol 2020 Aug;122(2):176-182 PMID: 32383268 SCOPUS ID: 2-s2.0-85085151262 05/10/2020       8 Citations
  • The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC. (Turgeon MK, Gamboa AC, Lee RM, Zaidi MY, Kimbrough C, Grotz T, Fournier K, Powers B, Dineen S, Veerapong J, Clarke C, Mogal H, Patel SH, Lambert L, Ronnekleiv-Kelly S, Raoof M, Fackche N, Greer JB, Staley CA, Cloyd JM, Maithel SK, Winer JH) Ann Surg Oncol 2020 Dec;27(13):4894-4907 PMID: 32378087 PMCID: PMC7644621 SCOPUS ID: 2-s2.0-85085094642 05/08/2020       12 Citations
  • Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. (Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:500 PMID: 32363161 PMCID: PMC7180175 SCOPUS ID: 2-s2.0-85084152103 05/05/2020       10 Citations
  • Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S) HPB (Oxford) 2020 Dec;22(12):1745-1752 PMID: 32354656 SCOPUS ID: 2-s2.0-85083782398 05/02/2020       2 Citations
  • Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. (Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:460 PMID: 32351886 PMCID: PMC7175033 SCOPUS ID: 2-s2.0-85084010622 05/01/2020       19 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Standards. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1743-1752 PMID: 32285276 SCOPUS ID: 2-s2.0-85083312765 04/15/2020       17 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1753-1760 PMID: 32285275 SCOPUS ID: 2-s2.0-85083306571 04/15/2020       57 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1788-1792 PMID: 32285274 SCOPUS ID: 2-s2.0-85083342085 04/15/2020       15 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1774-1779 PMID: 32285273 SCOPUS ID: 2-s2.0-85083287924 04/15/2020       21 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1761-1767 PMID: 32285270 SCOPUS ID: 2-s2.0-85083315214 04/15/2020       38 Citations
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1768-1773 PMID: 32285269 SCOPUS ID: 2-s2.0-85083329258 04/15/2020       22 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2547-2552 PMID: 32282077 SCOPUS ID: 2-s2.0-85085874972 04/14/2020       23 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2541-2546 PMID: 32282074 SCOPUS ID: 2-s2.0-85084607559 04/14/2020       26 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2525-2533 PMID: 32282073 SCOPUS ID: 2-s2.0-85084594927 04/14/2020       34 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2566-2570 PMID: 32282072 SCOPUS ID: 2-s2.0-85084537054 04/14/2020       9 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2534-2540 PMID: 32282070 SCOPUS ID: 2-s2.0-85085886163 04/14/2020       20 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2561-2565 PMID: 32282069 SCOPUS ID: 2-s2.0-85084603901 04/14/2020       9 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2553-2560 PMID: 32282068 SCOPUS ID: 2-s2.0-85085884282 04/14/2020       14 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Standards. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2516-2524 PMID: 32282066 SCOPUS ID: 2-s2.0-85085694523 04/14/2020       10 Citations
  • The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2571-2576 PMID: 32282059 SCOPUS ID: 2-s2.0-85084626057 04/14/2020       10 Citations
  • Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. (Shelby RD, Suarez-Kelly LP, Yu PY, Hughes TM, Ethun CG, Tran TB, Poultsides G, King DM, Bedi M, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Howard JH, Cardona K, Grignol V) J Surg Oncol 2020 Jun;121(8):1249-1258 PMID: 32232871 SCOPUS ID: 2-s2.0-85082526705 04/02/2020       7 Citations
  • PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC. (Schwartz PB, Poultsides G, Roggin K, Howard JH, Fields RC, Clarke CN, Votanopoulos K, Cardona K, Winslow ER) J Surg Res 2020 Jul;251:228-238 PMID: 32172009 PMCID: PMC7765565 SCOPUS ID: 2-s2.0-85081277681 03/17/2020       18 Citations
  • Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. (Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative) J Surg Oncol 2020 Jun;121(7):1140-1147 PMID: 32167587 SCOPUS ID: 2-s2.0-85081732672 03/14/2020       8 Citations
  • Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review. (Beal EW, Suarez-Kelly LP, Kimbrough CW, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Lee B, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Dhar V, Lambert L, Hendrix RJ, Hays J, Abdel-Misih S, Cloyd JM) J Clin Med 2020 Mar 10;9(3) PMID: 32164300 PMCID: PMC7141272 SCOPUS ID: 2-s2.0-85085114386 03/14/2020       27 Citations
  • Screening guidelines and recommendations for patients at high risk of developing endocrine cancers. (Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN) J Surg Oncol 2020 May;121(6):975-983 PMID: 32090344 SCOPUS ID: 2-s2.0-85083530980 02/25/2020       6 Citations
  • What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative. (Lee RM, Zaidi MY, Gamboa AC, Speegle S, Kimbrough CW, Cloyd JM, Leiting JL, Grotz TE, Lee AJ, Fournier KF, Powers BD, Dineen SP, Baumgartner J, Veerapong J, Clarke CN, Sussman JJ, Patel S, Hendrix RJ, Lambert LA, Vande Walle KA, Abbott DE, LaRocca CJ, Raoof M, Fackche N, Johnston FM, Staley CA, Maithel SK, Russell MC) Clin Colorectal Cancer 2020 Mar;19(1):e1-e7 PMID: 31974019 SCOPUS ID: 2-s2.0-85078611742 01/25/2020       13 Citations
  • Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. (Lee TC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Zaidi MY, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Greer J, Patel SH) J Gastrointest Surg 2020 Jan;24(1):165-176 PMID: 31745888 SCOPUS ID: 2-s2.0-85075259444 11/21/2019       26 Citations
  • Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. (Silva-Figueroa AM, Bassett R Jr, Christakis I, Moreno P, Clarke CN, Busaidy NL, Grubbs EG, Lee JE, Perrier ND, Williams MD) Endocr Pathol 2019 Dec;30(4):285-296 PMID: 31734935 SCOPUS ID: 2-s2.0-85076378963 11/18/2019       20 Citations
  • Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. (Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC) Ann Surg Oncol 2020 Apr;27(4):1156-1163 PMID: 31677109 SCOPUS ID: 2-s2.0-85074715626 11/05/2019       8 Citations
  • Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? (Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM) Ann Surg Oncol 2020 Mar;27(3):783-792 PMID: 31659645 SCOPUS ID: 2-s2.0-85074730542 10/30/2019       21 Citations
  • Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. (Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S) Ann Surg Oncol 2019 Dec;26(13):4515-4521 PMID: 31641946 SCOPUS ID: 2-s2.0-85074492297 10/24/2019       7 Citations
  • Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. (Zaidi MY, Lee RM, Gamboa AC, Speegle S, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Kelly KJ, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Hendrix RJ, Lambert L, Ronnekleiv-Kelly S, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Fackche N, Russell MC, Maithel SK, Staley CA 3rd) Ann Surg Oncol 2020 Jan;27(1):156-164 PMID: 31602579 PMCID: PMC7195626 SCOPUS ID: 2-s2.0-85074522191 10/12/2019       14 Citations
  • Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review. (Stein A, Strong E, Clark Gamblin T, Clarke C, Tsai S, Thomas J, George B, Mogal H) Ann Surg Oncol 2020 Jan;27(1):85-97 PMID: 31583543 SCOPUS ID: 2-s2.0-85074461946 10/05/2019       20 Citations
  • Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. (Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI) J Surg Oncol 2019 Dec;120(7):1227-1234 PMID: 31486096 PMCID: PMC6857791 SCOPUS ID: 2-s2.0-85071749994 09/06/2019       26 Citations
  • Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. (Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH) J Gastrointest Surg 2020 Jan;24(1):155-164 PMID: 31428960 SCOPUS ID: 2-s2.0-85071097497 08/21/2019       25 Citations
  • Genetic profiling as a clinical tool in advanced parathyroid carcinoma (Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NL) Journal of Cancer Research and Clinical Oncology 1 August 2019;145(8):1977-1986 SCOPUS ID: 2-s2.0-85068957150 08/01/2019       30 Citations
  • Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC). (Schwartz PB, Vande Walle K, Winslow ER, Ethun CG, Tran TB, Poultsides G, Tseng J, Roggin K, Grignol V, Howard JH, Krasnick BA, Fields RC, Mogal H, Clarke CN, Senehi R, Votanopoulos K, Cardona K, Abbott DE) Sarcoma 2019;2019:5395131 PMID: 31281208 PMCID: PMC6589263 SCOPUS ID: 2-s2.0-85067822528 07/10/2019       9 Citations
  • Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. (Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK) Surgery 2019 Sep;166(3):277-285 PMID: 31272811 SCOPUS ID: 2-s2.0-85068174272 07/06/2019       42 Citations
  • Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. (Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK) Ann Surg Oncol 2020 Jan;27(1):134-146 PMID: 31243668 PMCID: PMC6925634 SCOPUS ID: 2-s2.0-85068213309 06/28/2019       12 Citations
  • Editorial: Small, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors: Observation becoming standard of care? (Clarke CN, Evans DB) Surgery 2019 Aug;166(2):164-165 PMID: 31097321 SCOPUS ID: 2-s2.0-85065533808 05/18/2019       2 Citations
  • Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. (Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ) Ann Surg Oncol 2019 Jul;26(7):2234-2240 PMID: 31016486 SCOPUS ID: 2-s2.0-85064812267 04/25/2019       15 Citations
  • RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. (Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN) J Surg Res 2019 Aug;240:130-135 PMID: 30928770 SCOPUS ID: 2-s2.0-85063410472 04/01/2019       12 Citations
  • Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways. (Clarke CN, Katsonis P, Hsu TK, Koire AM, Silva-Figueroa A, Christakis I, Williams MD, Kutahyalioglu M, Kwatampora L, Xi Y, Lee JE, Koptez ES, Busaidy NL, Perrier ND, Lichtarge O) J Endocr Soc 2019 Mar 01;3(3):544-559 PMID: 30788456 PMCID: PMC6372985 SCOPUS ID: 2-s2.0-85070515026 02/23/2019       39 Citations
  • Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. (Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC) J Am Coll Surg 2019 Mar;228(3):245-254 PMID: 30639515 SCOPUS ID: 2-s2.0-85060157296 01/15/2019       8 Citations
  • The history of isolated hepatic perfusion for liver metastases and current indications for use (Clarke CN, Alexander HR, Quebbeman EJ, Gamblin TC) Cancer Regional Therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond 1 January 2019:247-256 SCOPUS ID: 2-s2.0-85086955805 01/01/2019    
  • Treatment Sequencing for Borderline Resectable Pancreatic Cancer (Clarke CN) Management of Localized Pancreatic Cancer: Current Treatment and Challenges 1 January 2019:55-65 SCOPUS ID: 2-s2.0-85150104111 01/01/2019    
  • Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. (Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN) J Surg Res 2019 Jan;233:154-162 PMID: 30502242 SCOPUS ID: 2-s2.0-85051762456 12/07/2018       5 Citations
  • Distal splenorenal and mesocaval shunting at the time of pancreatectomy. (Chavez MI, Tsai S, Clarke CN, Aldakkak M, Griffin MO, Khan AH, Ritch PS, Erickson BA, Evans DB, Christians KK) Surgery 2019 Feb;165(2):298-306 PMID: 30471779 SCOPUS ID: 2-s2.0-85056892124 11/26/2018       12 Citations
  • Pancreatic neuroendocrine tumors (Yao JC, Clarke CN, Evans DB) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology 16 November 2018:1353-1367 SCOPUS ID: 2-s2.0-85061201430 11/16/2018    
  • Elective Regional Therapy Treatment for Hepatic Adenoma. (Silva JP, Klooster B, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T) Ann Surg Oncol 2019 Jan;26(1):125-130 PMID: 30353390 SCOPUS ID: 2-s2.0-85055702464 10/26/2018       8 Citations
  • Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. (Silva-Figueroa A, Villalobos P, Williams MD, Bassett RL Jr, Clarke CN, Lee JE, Busaidy NL, Perrier ND) Surgery 2018 Nov;164(5):960-964 PMID: 30033186 SCOPUS ID: 2-s2.0-85050134269 07/24/2018       15 Citations
  • Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence. (Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC) J Surg Oncol 2018 Jun;117(8):1664-1671 PMID: 29714811 SCOPUS ID: 2-s2.0-85046125870 05/02/2018       5 Citations
  • The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network. (Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC) Surgery 2018 May;163(5):1028-1034 PMID: 29398041 SCOPUS ID: 2-s2.0-85041576936 02/06/2018       8 Citations
  • Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatment. (Korphaisarn K, Chou CK, Xia WY, Clarke CN, Katkhuda R, Davis JS, Raghav KP, Liao HW, Wu JY, Menter DG, Maru DM, Hung MC, Kopetz S) Am J Cancer Res 2017;7(12):2587-2599 PMID: 29312811 PMCID: PMC5752698 01/10/2018    
  • Cancer of the colon, rectum, and anus (Clarke CN, You YN, Feig BW) The MD Anderson Surgical Oncology Handbook, Sixth Edition 1 January 2018:304-356 SCOPUS ID: 2-s2.0-85051541420 01/01/2018       1 Citation
  • Molecular Markers and Mutational Analysis (Clarke CN, Kopetz ES) Rectal Cancer: Modern Approaches to Treatment 1 January 2018:295-312 SCOPUS ID: 2-s2.0-85076048955 01/01/2018       1 Citation
  • Minimally invasive hepatectomy conversions: an analysis of risk factors and outcomes. (Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T) HPB (Oxford) 2018 Feb;20(2):132-139 PMID: 29183702 SCOPUS ID: 2-s2.0-85034837878 12/01/2017       21 Citations
  • Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. (Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC) Surgery 2018 Feb;163(2):318-323 PMID: 28943041 SCOPUS ID: 2-s2.0-85029656379 09/26/2017       29 Citations
  • Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. (Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S) Ann Surg Oncol 2017 Dec;24(13):4051-4058 PMID: 28936799 PMCID: PMC6063735 SCOPUS ID: 2-s2.0-85029712949 09/25/2017       23 Citations
  • Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Nov;21(11):1793-1803 PMID: 28849366 SCOPUS ID: 2-s2.0-85028529403 08/30/2017       24 Citations
  • The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. (Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC) J Surg Oncol 2017 Dec;116(7):831-840 PMID: 28743160 SCOPUS ID: 2-s2.0-85026398495 07/26/2017       28 Citations
  • Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. (Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC) HPB (Oxford) 2017 Aug;19(8):659-666 PMID: 28552299 SCOPUS ID: 2-s2.0-85019962593 05/30/2017       80 Citations
  • Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. (Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA) HPB (Oxford) 2017 Aug;19(8):706-712 PMID: 28528267 SCOPUS ID: 2-s2.0-85020090602 05/22/2017       4 Citations
  • External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. (Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC) J Surg Oncol 2017 Sep;116(3):307-312 PMID: 28464313 SCOPUS ID: 2-s2.0-85018739094 05/04/2017       16 Citations
  • Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. (Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Grubbs EG, Lee JE, Busaidy NL, Perrier ND) J Am Coll Surg 2017 Mar 15 PMID: 28427885 SCOPUS ID: 2-s2.0-85017457553 04/22/2017       34 Citations
  • Arginine methylation of EGFR: A new biomarker for predicting resistance to anti-EGFR treatment (Korphaisarn K, Chou CK, Xia WY, Clarke CN, Katkhuda R, Davis JS, Raghav KPS, Liao HW, Wu JY, Menter DG, Maru DM, Hung MC, Kopetz S) American Journal of Cancer Research 2017;7(12):2587-2599 SCOPUS ID: 2-s2.0-85039069392 01/01/2017       2 Citations
  • Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. (Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN) Ann Surg 2018 Mar;267(3):514-520 PMID: 28002060 PMCID: PMC5901745 SCOPUS ID: 2-s2.0-85007198120 12/22/2016       58 Citations
  • Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures. (Clarke CN, Patel SH, Day RW, George S, Sweeney C, Monetes De Oca GA, Aiss MA, Grubbs EG, Bednarski BK, Lee JE, Bodurka DC, Skibber JM, Aloia TA) Surgery 2017 Mar;161(3):869-875 PMID: 27825699 SCOPUS ID: 2-s2.0-85006117336 11/09/2016       13 Citations
  • Oncologic progress for the treatment of parathyroid carcinoma is needed. (Christakis I, Silva AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND) J Surg Oncol 2016 Nov;114(6):708-713 PMID: 27753088 SCOPUS ID: 2-s2.0-84992473912 10/30/2016       28 Citations
  • Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. (Christakis I, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND) Int J Surg 2016 Jul;31:10-6 PMID: 27212590 SCOPUS ID: 2-s2.0-84971452301 05/24/2016       41 Citations
  • Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. (Christakis I, Bussaidy N, Clarke C, Kwatampora LJ, Warneke CL, Silva AM, Williams MD, Grubbs EG, Lee JE, Perrier ND) Ann Surg Oncol 2016 Sep;23(9):2889-97 PMID: 27160525 SCOPUS ID: 2-s2.0-84966669922 05/11/2016       39 Citations
  • BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. (Clarke CN, Kopetz ES) J Gastrointest Oncol 2015 Dec;6(6):660-7 PMID: 26697199 PMCID: PMC4671844 SCOPUS ID: 2-s2.0-84995752465 12/24/2015       159 Citations
  • Factors affecting readmission after pancreaticoduodenectomy. (Clarke CN, Sussman JJ, Abbott DE, Ahmad SA) Adv Surg 2013;47:99-110 PMID: 24298846 SCOPUS ID: 2-s2.0-84880961238 12/05/2013       10 Citations
  • The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis. (Tevar AD, Clarke CN, Schuster R, Wang J, Edwards MJ, Lentsch AB) J Surg Res 2011 Jul;169(1):e7-14 PMID: 21492876 PMCID: PMC4599341 SCOPUS ID: 2-s2.0-79958195503 04/16/2011       13 Citations
  • CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury. (Clarke C, Kuboki S, Sakai N, Kasten KR, Tevar AD, Schuster R, Blanchard J, Caldwell CC, Edwards MJ, Lentsch AB) Hepatology 2011 Jan;53(1):261-71 PMID: 21254176 PMCID: PMC3058860 SCOPUS ID: 2-s2.0-78751535909 01/22/2011       41 Citations
  • Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury. (Goodman MD, Makley AT, Huber NL, Clarke CN, Friend LA, Schuster RM, Bailey SR, Barnes SL, Dorlac WC, Johannigman JA, Lentsch AB, Pritts TA) J Surg Res 2011 Jan;165(1):30-7 PMID: 20850781 PMCID: PMC4607063 SCOPUS ID: 2-s2.0-78649962095 09/21/2010       50 Citations
  • Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes. (Sakai N, Clarke CN, Schuster R, Blanchard J, Tevar AD, Edwards MJ, Lentsch AB) World J Gastroenterol 2010 Aug 14;16(30):3816-26 PMID: 20698045 PMCID: PMC2921094 SCOPUS ID: 2-s2.0-77955767741 08/11/2010       11 Citations
  • STAT3 does not regulate acute liver injury after ischemia/reperfusion. (Clarke C, Sakai N, Tevar AD, Schuster R, Edwards MJ, Lentsch AB) J Surg Res 2011 Dec;171(2):814-8 PMID: 20599212 PMCID: PMC2965827 SCOPUS ID: 2-s2.0-81155153772 07/06/2010       3 Citations
  • Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. (Tevar AD, Clarke C, Wang J, Rudich SM, Woodle ES, Lentsch AB, Edwards ML) J Am Coll Surg 2010 Apr;210(4):515-26 PMID: 20347746 PMCID: PMC4607044 SCOPUS ID: 2-s2.0-77949891998 03/30/2010       31 Citations
  • CXC chemokines play a critical role in liver injury, recovery, and regeneration. (Clarke CN, Kuboki S, Tevar A, Lentsch AB, Edwards M) Am J Surg 2009 Sep;198(3):415-9 PMID: 19716886 PMCID: PMC2736150 SCOPUS ID: 2-s2.0-69249119868 09/01/2009       47 Citations
  • The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury. (Kuboki S, Sakai N, Clarke C, Schuster R, Blanchard J, Edwards MJ, Lentsch AB) J Hepatol 2009 Aug;51(2):296-306 PMID: 19515451 PMCID: PMC2747648 SCOPUS ID: 2-s2.0-67649195819 06/12/2009       40 Citations
  • Equine-related injury: a retrospective analysis of outcomes over a 10-year period. (Clarke CN, Tsuei BJ, Butler KL) Am J Surg 2008 May;195(5):702-4 PMID: 18424291 SCOPUS ID: 2-s2.0-42049084367 04/22/2008       28 Citations
  • Changing the substrate specificity of creatine kinase from creatine to glycocyamine: evidence for a highly evolved active site. (Jourden MJ, Clarke CN, Palmer AK, Barth EJ, Prada RC, Hale RN, Fraga D, Snider MJ, Edmiston PL) Biochim Biophys Acta 2007 Dec;1774(12):1519-27 PMID: 17976392 SCOPUS ID: 2-s2.0-36849031248 11/03/2007       12 Citations
  • Last update: 03/19/2024